The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "research institutions" ...
-
Diploma Mill
A series of stories from the Virgin Islands Daily News, "Diploma Mill" reveals that the V.I. government was working with and enabling a diploma mill to target V.I. teachers. The author's research indicates that the institution was not a school, but was instead a "diploma-generating business that had ties to a questionable online operation."
Tags: diploma mill; teacher certification; accreditation; Virgin Islands; buying diplomas; teacher's union
-
Beyond the Breach
Using accident reports from the Army's top biodefense laboratory as well as a report on a 2002 incident involving the discovery of Anthrax spores near laboratories, the News-Post found that while the Army had made efforts to improve safety, accidents attributable to negligence and carelessness still occurred. The investigation focuses on the U.S. Army Medical Research Institute of Infectious Diseases.
Tags: U.S. Army Medical Research Institute of Infectious Diseases; U.S. Army Medical Research and Materiel Command; ebola; anthrax; infectious diseases; safety, health
-
Dangerous Remedy
Robert Little of The (Baltimore) Sun reported that the U.S. Army has injected over 1000 soldiers wounded in Iraq with a medicine designed for hemophiliacs despite the fact that it is dangerous for people with normal blood. It can give them blood clots that could cause strokes and heart attacks. It costs $6000 per dose. Civilian doctors "have largely rejected it as a standard treatment for trauma patients." Army doctors say, in their experience, the drug saves lives by stopping hemorrhaging. Little says “Doctors in Iraq's emergency rooms, however, almost never care for their patients long enough to see firsthand whether blood clots or other complications have developed." Little reports that "the drug has never been subjected to a large-scale clinical trial to verify that it works and is safe for patients without hemophilia."
Tags: military medical system; Iraq; coagulant; Institute for Surgical Research; Germany; military hospitals; Food and Drug Administration; FDA; U.S. Department of Defense; DoD; Marines; Assistant Secretary of Defense for Health Affairs; U.S. Army Surgeon General; HIPPA; actionable intelligence; Recombinant Activated Factor VII; Novo Nordisk; coagulopathic bleeding;
-
UNLV Institute for Security Studies
"The institute, formed in the aftermath of the 9/11 terrorist attacks, was intended as UNLV's contribution to the war on terrorism. The institute began with a promise of delivering research and education in part by tapping into professionals who had worked at the Nevada Test Site." Yet it seems to not be meeting its promise.
Tags: terrorism; college; studies; September 11; security
-
MIT Professor Sacked for Fabricating Data
The author's investigation uncovered a pattern of suspicious data in the work of a high-flying biology professor at MIT. The implicated research went back 8 years, involved laboratories at three of the top research institutions in the United States and millions of dollars in federal research money.
Tags: science; scientific research; scientific fraud; research laboratories; immunology; research institutions; Dr. Van Parijs
-
The $800 million pill: The truth behind the cost of new drugs
In this book, the author disproves the pharmaceutical industry's assertions that it is the primary originator of new drugs and that it costs $800 million to bring a new drug to market. The investigation found that most of the important and life-saving drugs of the past 25 years originated at taxpayer-funded universities and at the National Institutes of Health. The author contends that American taxpayers foot the bill twice for prescription drugs: once by supporting government funded research and again by paying the pharmaceutical industry's high prices.
Tags: BOOK; prescription drugs; medicine; pharmaceutical industry; drug companies; National Institutes of Health
-
Danger Zone
The Gazette investigation found that nearly half the fatal accidents on Interstate 80 in Iowa from 1994-2001 involved semi-trailer trucks. No other interstate in Iowa had a rate that high. Traffic counts are growing on a 60-70 mile stretch of I-80 in Eastern Iowa, where many of the semi-trailer trucks are concentrated. Despite the growth in traffic, state officials have no plans to improve safety by widening the highway because traffic counts are just shy of the threshold for widening the road.
Tags: fatal accidents; Interstate 80; semi-trailer trucks; traffic accidents; Fatality Analysis Reporting System; stopping distance; Iowa Department of Transportation; Iowa Office of Driver Services; Iowa Office of Motor Vehicle Enforcement; Iowa Office of Design; University of Michigan Transportation Research Institute; Cedar County; Iowa State Patrol; FARS
-
Hepatitis C: Silent Alarm
This series documented the government's numerous failures to warn the American public about hepatitis C, a disease that has infected more than 4 million people in the United States. The series found that the federal government promised repeatedly to raise a public alarm about the disease but reneged almost every time. As a result, most people with hepatitis C don't even know they have it and may be spreading it. The series also found that Congress and CDC give hepatitis C a fraction of the funding and attention they give other disease such as West Nile, that has killed several hundreds. The government promised a search to find nearly two hundred thousand patients who received infected blood transfusions before 1992, when a test was available to screen out infected blood, but four years later, the campaign had stalled. The blood industry in the 1980's delayed a screening test six years that could have prevented hepatitis C in more than 300,000 patients who received blood transfusions. the government never ordered the test even though it was aware of the seriousness of the disease.
Tags: hepatitis c; virus; AIDS; public alarm; Congress; Center for Disease Control and Prevention; HCV; funding; West Nile; infected blood transfusions; infected blood; blood industry; screening test; donated blood; CDC; CDC spending; HCV money; National Institute of Health; Health and Human Services; U.S. Food and Drug Administration; FDA's Office of Blood Research and Review; Blood Products Advisory Committee; Advisory Committee on Blood Safety and Availability; blood banks; Community Blood Center of Kansas City; Oklahoma Blood Institute
-
Stealth Merger: Drug Companies and Government Medical Research
This investigation is about how the National Institute of Health allows its scientists to take side jobs as consultants for drug companies. The articles show how this conflict of interest can affect their work, and how it can be detrimental to the health of America. Not only does the agency allow for the conflict of interest, but it allows top-paid employees to keep their consulting confidential.
Tags: pharmaceutical industry; drug companies; NIH; FDA
-
Silence in Class
An agreement between the University of California and industry, while cost-effective, could seriously undermine the goals of science. Over the nest four years, the state plans to build three Institutes for Science and Innovation, made only partly with state funds. The rest will come from private industry, a move that could seriously hinder the viability of any research taking place at the facilities.
Tags: colleges; universities; business